SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

Share Price is delayed by 15 minutes
Get Live Data
1.795    0.00 (0.00%)
Bid:
1.77
Ask:
1.82
Spread: 0.05 (2.825%)
Market Cap: $75.42m
LSAA Live PriceLast checked at - London Stock Exchange

Intraday Life Settlemen Share Chart

Portfolio Update

25 Jun 2025 07:00

RNS Number : 2659O
Life Settlement Assets PLC
25 June 2025
 

This announcement contains inside information

 

Life Settlement Assets PLC (the "Company" or "LSAA")

LEI: 2138003OL2VBXWG1BZ27

Portfolio Update

 

Update on review of policies held by third party agent, Vespera Servicing LLC("Vespera")

 

 

At the Company's year-end results, which were announced on 29 April 2025, it was stated that the Company would carry out a detailed review of all LSA's Mutual Benefits Keep Policy Trust ("MBC") policies now held on the Company's behalf by Vespera, LSA's third-party servicing agent. This followed the announcement on 28 March 2025 when the Company reported the background to the incorrect valuation of a life policy held for LSA's account.

 

The Board can report that the review process has now largely been completed and our findings to date give us confidence that there are no other policies that have been overvalued.

 

Further, from the extra visibility provided by the transfer and consolidation of all our policies at Vespera, the Board has been advised that the valuation of one particular group of policies should be increased by US$3 million which equates to an uplift in NAV of approximately 3%. This increase will be reflected in our next NAV release, which is expected in the first week of July 2025.

 

Chairman Michael Baines, said:

 

 "At our year-end announcement, we reported the successful conclusion of the long-running MBC process. We are delighted now to have direct control of our MBC policies and have confidence that no other policies have been overvalued. We place strong emphasis on having the right processes in place to ensure accurate valuations, and this will remain a key focus going forward."

 

For further information, please contact:

 

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

 

Shore Capital (Financial Adviser and Broker)

Gillian Martin / Anita Ghanekar / Harry Davies-Ball

020 7408 4090

 

 

ISCA Administration Services Limited (the Company Secretary) on

01392 487056; or lsa@iscaadmin.co.uk

 

 

 

25 June 2025

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUUSVARVAUNUUR
Date   Source Headline
9th Jun 20266:13 pmRNSResult of AGM
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20262:56 pmRNSNet Asset Value(s)
1st Jun 20269:21 amRNSTotal Voting Rights
26th May 20269:08 amRNSTransaction in Own Shares
18th May 20269:11 amRNSTransaction in Own Shares
12th May 20268:06 amRNSTransaction in Own Shares
11th May 20267:25 amRNSTransaction in Own Shares
7th May 20266:10 pmRNSTransaction in Own Shares
7th May 20268:23 amRNSTransaction in Own Shares
6th May 20261:50 pmRNSNet Asset Value(s)
5th May 20268:54 amRNSTransaction in Own Shares
1st May 20263:30 pmRNSTotal Voting Rights
28th Apr 20265:42 pmRNSTransaction in Own Shares
28th Apr 20267:00 amRNSFinal Results
22nd Apr 20268:13 amRNSTransaction in Own Shares
13th Apr 20261:42 pmRNSNet Asset Value(s)
1st Apr 20268:19 amRNSTotal Voting Rights
25th Mar 20267:00 amRNSNet Asset Value(s)
20th Mar 202611:20 amRNSTransaction in Own Shares
19th Mar 20268:52 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSShare Buyback Programme
16th Mar 20267:00 amRNSShare Buyback Programme
9th Mar 20267:02 amRNSNet Asset Value(s)
9th Mar 20267:00 amRNSPortfolio Update
7th Jan 20265:46 pmRNSNet Asset Value(s)
18th Dec 20255:46 pmRNSNet Asset Value(s)
27th Nov 20257:00 amRNSAppointment of Corporate Broker
11th Nov 20252:23 pmRNSNet Asset Value(s)
7th Oct 20251:57 pmRNSNet Asset Value(s)
29th Sep 20257:00 amRNSResults for the Half Year ended 30 June 2025
29th Aug 20251:00 pmRNSNet Asset Value(s)
31st Jul 20259:50 amRNSNet Asset Value(s)
4th Jul 20254:06 pmRNSNet Asset Value(s)
1st Jul 20259:33 amRNSTotal Voting Rights
26th Jun 20255:32 pmRNSDirector Declaration
25th Jun 20257:00 amRNSPortfolio Update
18th Jun 20252:47 pmRNSAGM Statement
18th Jun 202511:23 amRNSNet Asset Value(s)
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 202511:55 amRNSNet Asset Value(s)
2nd Jun 202510:51 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
1st May 202512:21 pmRNSNet Asset Value(s)
1st May 202512:12 pmRNSNet Asset Value(s)
1st May 20259:23 amRNSTotal Voting Rights
29th Apr 20257:00 amRNSFinal Results
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.